Ye Seul Kim

Ye Seul Kim

Auto-generated profile, based on publicly available information

Ye Seul Kim

Department of Physiology Department of Convergence Stem Cell Research Center School of Medicine Pusan National University Yangsan Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
YKYe Seul Kim
Ye Seul Kim
SYSukdong Yoo
Sukdong Yoo
YJYoon Ji Jung
Yoon Ji Jung
JYJung Won Yoon
Jung Won Yoon
YKYong Seong Kwon
Yong Seong Kwon
JKJae Ho Kim
Jae Ho Kim
Barth syndrome (BTHS) is an ultrarare, infantile-onset, X-linked recessive mitochondrial disorder that primarily affects males, owing to mutations in TAFAZZIN, which catalyzes the remodeling of cardiolipin, a mitochondrial phospholipid required for oxidative phosphorylation. Mitochondrial transplantation is a novel technique to treat mitochondrial dysfunction by delivering healthy mitochondria to diseased cells or tissues. Here we explored the possibility of using stem-cell-derived cardiomyocytes as a source of mitochondrial transplantation to treat BTHS. We established induced pluripotent stem (iPS) cells from healthy individuals and from patients with BTHS and differentiated them into cardiomyocytes. The iPS-cell-differentiated cardiomyocytes (CMs) derived from patients with BTHS exhibited less expression of cardiomyocytes markers, such as α-SA, cTnT and cTnI, and smaller cell size than normal iPS-cell-derived CMs. Multielectrode array analysis revealed that BTHS CMs exhibited shorter beat period and longer field potential duration than normal CMs. In addition, mitochondrial morphology and function were impaired and mitophagy was decreased in BTHS CMs compared with normal CMs. Transplantation of mitochondria isolated from normal CMs induced mitophagy in BTHS CMs, mitigated mitochondrial dysfunction and promoted mitochondrial biogenesis. Furthermore, mitochondrial transplantation stimulated cardiac maturation and alleviated cardiac arrhythmia of BTHS CMs. These results suggest that normal CMs are useful for allogeneic transplantation in the treatment of mitochondrial diseases, including BTHS.

30 March 2026 in Advanced Science
Verified
Journal Article
Open access
PDF file
YKYe Seul Kim
Ye Seul Kim
JJJeonghwa Jeong
Jeonghwa Jeong
GHGyeonghwa Heo
Gyeonghwa Heo
YKYoung Woo Kwon
Young Woo Kwon
JLJeongha Lee
Jeongha Lee
JKJae Ho Kim
Jae Ho Kim
We present an integrated microelectrode array (MEA) platform for high‐precision electrophysiological characterization of patient‐derived 3D cardiac organoids (COs), enabling dynamic recordings from both healthy and Duchenne muscular dystrophy (DMD) “mini‐hearts.” A deformable MEA, fabricated by photolithographic patterning of support layers and microelectrodes, is conformally assembled onto a customized scoop‐slide well. The concave geometry enables passive self‐alignment of millimeter‐scale COs within a multichannel electrode array, allowing simultaneous extracellular field potential (EFP) recording and video‐based motion analysis. Using COs derived from human induced pluripotent stem cells of healthy donors and a DMD patient, we resolved region‐specific EFP waveforms, which were validated by calcium imaging. DMD COs exhibited severe arrhythmic firing and aberrant waveform morphologies, in contrast to the stable, isochronal rhythms of healthy controls. Single‐cell transcriptomic analysis revealed a pathological DMD signature marked by excessive extracellular matrix accumulation and disorganized cardiac architecture, contributing to conduction heterogeneity. Pharmacological challenge with the hERG blocker E‐4031 prolonged field potential duration in normal COs but triggered disorganized arrhythmogenic storms in DMD COs. By overcoming the limitations of rigid interfaces and ensuring structural preservation with stable impedance coupling, the presented platform provides a robust biointerface for disease phenotyping, drug screening, and mechanistic interrogation of 3D cardiac tissues.

5 August 2025 in International Journal of Stem Cells
Verified
Journal Article
Open access
PDF file
HMHye Ji Moon
Hye Ji Moon
NLNayeon Lee
Nayeon Lee
BLBo Seok Lee
Bo Seok Lee
MPMin Seok Park
Min Seok Park
YJYoon Ji Jung
Yoon Ji Jung
JKJae Ho Kim
Jae Ho Kim
Hye Ji Moon, Nayeon Lee, Bo Seok Lee, Min Seok Park, Yoon Ji Jung, Ye Seul Kim, Jae Ho Kim. IJSC -0001;0:. https://doi.org/10.15283/ijsc25023

31 July 2026 in BMB Reports
Verified
Journal Article
Open access
PDF file
YKYe Seul Kim
Ye Seul Kim
DKDasol Kim
Dasol Kim
YJYoon Ji Jung
Yoon Ji Jung
JYJung Won Yoon
Jung Won Yoon
YKYong Seong Kwon
Yong Seong Kwon
JKJae Ho Kim
Jae Ho Kim
Ye Seul Kim, Dasol Kim, Yoon Ji Jung, Jung Won Yoon, Yong Seong Kwon, Youngmi Kim Pak, Seong-Jang Kim & Jae Ho Kim. BMB Reports 2026;59:356-63. https://doi.org/10.5483/BMBRep.2025-0024

26 October 2026 in Advanced Functional Materials
Verified
Journal Article
Closed access
SKSung Dong Kim
Sung Dong Kim
SWShibo Wei
Shibo Wei
YZYan Zhang
Yan Zhang
WPWonyoung Park
Wonyoung Park
TDTam Dao
Tam Dao
Mikyung ShinMikyung Shin
Mikyung Shin